Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
IV Infusion in New Braunfels IV Infusion in New Braunfels New Braunfels has several IV infusion options besides NAD+
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
Description Gut Revival peptide bundle a curated three-peptide research stack combining BPC-157, KPV, and Thymosin Alpha-1, formulated for comprehensive gut health and immune regulation research
For those situations, injections are not optional - they correct a biologic shortfall and prevent neurologic harm
Hours posted online are 10 a.m.-8 p.m
For example, researchers have tested BPC-157 enemas as a treatment for ulcerative colitis in a pair of clinical trials conducted by the Croatian pharmaceutical company PLIVA in the 2000s
